E-LIB Suche - Ergebnisse für: Kurkjian, Carla

1

Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) ..:

Shapiro, Geoffrey I. ; LoRusso, Patricia ; Kwak, Eunice...
Investigational New Drugs. 38 (2019) 2 - p. 419-432 , 2019

2

A phase I, open-label, two-stage study to investigate the s..:

Aghajanian, Carol ; Bell-McGuinn, Katherine M. ; Burris III, Howard A....
Investigational New Drugs. 36 (2018) 6 - p. 1016-1025 , 2018

Link: https://doi.org/10.1007/..

3

A Phase I, Open-Label, Two-Stage Study to Investigate the S..:

Aghajanian, Carol ; Bell-McGuinn, Katherine M ; Burris, Howard A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170741/. , 2018

Link: http://www.ncbi.nlm.nih...

4

Impact of Health Care Insurance Status on Treatment Outcome..:

Srour, Samer A. ; Machiorlatti, Michael ; Pierson, Namali T....
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 7 - p. 450-456.e2 , 2017

Link: https://doi.org/10.1016/..

5

A first-in-human phase I study of the oral Notch inhibitor,..:

Pant, Shubham ; Jones, Suzanne F. ; Kurkjian, Carla D....
European Journal of Cancer. 56 (2016) - p. 1-9 , 2016

Link: https://doi.org/10.1016/..

6

A phase 1 study of the sachet formulation of the oral dual ..:

Bendell, Johanna C. ; Kurkjian, Carla ; Infante, Jeffrey R....
Investigational New Drugs. 33 (2015) 2 - p. 463-471 , 2015

Link: https://doi.org/10.1007/..

7

Phase 1, Open-Label, Dose Escalation, Safety, and Pharmacok..:

Bendell, Johanna C ; Patel, Manish R ; Infante, Jeffrey R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406150/. , 2015

Link: http://www.ncbi.nlm.nih...

8

Targeted enzyme prodrug therapy for metastatic prostate can..:

Guillen, Katrin P ; Kurkjian, Carla ; Harrison, Roger G
Journal of Biomedical Science. 21 (2014) 1 - p. , 2014

Link: https://doi.org/10.1186/..

9

Phase 1, open‐label, dose escalation, safety, and pharmacok..:

Bendell, Johanna C. ; Patel, Manish R. ; Infante, Jeffrey R....
Cancer. 121 (2014) 7 - p. 1056-1063 , 2014

Link: https://doi.org/10.1002/..

10

Targeted enzyme prodrug therapy for metastatic prostate can..:

Guillen, Katrin P ; Kurkjian, Carla ; Harrison, Roger G
http://www.jbiomedsci.com/content/21/1/65. , 2014

Link: http://www.jbiomedsci.co..

11

A first-in-human dose-escalation study of ME-143, a second ..:

Pant, Shubham ; Burris III, Howard A. ; Moore, Kathleen...
Investigational New Drugs. 32 (2013) 1 - p. 87-93 , 2013

Link: https://doi.org/10.1007/..

12

A first-in-human dose-escalation study of ME-143, a second ..:

Pant, Shubham ; Burris, Howard A ; Moore, Kathleen...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913846. , 2013

Link: http://www.ncbi.nlm.nih...

13

Risks and benefits with bevacizumab: evidence and clinical ..:

Kurkjian, Carla ; Kim, Edward S
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2012

Link: http://www.ncbi.nlm.nih...

14

Risks and benefits with bevacizumab: evidence and clinical ..:

Kurkjian, Carla ; Kim, Edward S.
Therapeutic Advances in Drug Safety. 3 (2011) 2 - p. 59-69 , 2011

Link: https://doi.org/10.1177/..

15

Advances in the Treatment of Metastatic Colorectal Cancer:

Kurkjian, Carla ; Kummar, Shivaani
Disease-a-Month. 56 (2010) 4 - p. 187-203 , 2010

Link: https://doi.org/10.1016/..